News Focus
News Focus
Followers 6
Posts 389
Boards Moderated 0
Alias Born 02/06/2023

Re: None

Wednesday, 11/01/2023 8:35:28 PM

Wednesday, November 01, 2023 8:35:28 PM

Post# of 447440
Holt acknowledged the share price is under book valuation. Holt also made clear the statin-combo in not a priority. Holt also made clear thru savvy maneuvering, the company is gaining cash on hand. Holt didn't avoid the USA or UK challenges. But what Holt didn't say was how Vascepa may radically address Alzheimer's, nor should he. I suspect Holt like us is waiting to hear the results. For once, can we all come together, forget our differences, and hope beyond hope Vascepa should be prescribed to Alzheimer's patients. I'm done. Thank you.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News